Heparin Resistance - Clinical Perspectives and Management Strategies

N Engl J Med. 2021 Aug 26;385(9):826-832. doi: 10.1056/NEJMra2104091.

Authors

Jerrold H Levy¹, Jean M Connors¹

Affiliation

¹ From the Departments of Anesthesiology, Critical Care, and Surgery, Duke University School of Medicine, Durham, NC (J.H.L.); and the Hematology Division, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School - both in Boston (J.M.C.).

PMID: 34437785
DOI: 10.1056/NEJMra2104091

No abstract available

Publication types

Review

MeSH terms

Anticoagulants / pharmacology
Anticoagulants / therapeutic use*
Antithrombin III Deficiency
Antithrombins / therapeutic use
Blood Coagulation / drug effects
Blood Coagulation Tests
Blood Platelets / physiology
COVID-19 / blood
Drug Resistance*
Heparin / pharmacology
Heparin / therapeutic use*
Humans

Substances

Anticoagulants
Antithrombins
Heparin